| CAS No. | 1415817-34-3 |
| Molecular Formula | C15H30N |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
The occurrence of Mirogabalin Impurity 125 is closely related to bromine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Mirogabalin Impurity 125 (CAS 1415817-34-3), a pharmacopoeial impurity reference standard (molecular formula C15H30NBr, MW 304.32 g/mol) used for the identification and quantification of trace impurities in APIs.
Owing to bromine substitution, Mirogabalin Impurity 125 is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 304.32 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Mirogabalin Impurity 125 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C15H30N Br |
| Molecular Weight | 304.32 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 1.0 |
| CAS Registry Year (est.) | 1991 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 1 |